This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Leerink Swann Consulting Joins Navigant

Stocks in this article: NCI

Navigant (NYSE: NCI) announced today that it has acquired substantially all of the Life Sciences practice of Leerink Swann Consulting, LLC, the consulting arm of Leerink Holdings, LLC, a leading investment bank specializing in healthcare. The addition of 20 professionals increases Navigant Healthcare’s deep bench of experts who serve clients in the fast changing, competitive and highly regulated life sciences industry.

“With increased complexities in the pharmaceutical, biotech, medical device, diagnostic and biomarkers markets, we believe that our collective experience and ability to understand current and future trends will be a timely asset to our clients,” said Eduardo Schur, Managing Director and leader of Navigant’s global Life Sciences practice. “The combination of the two consulting practices in the life sciences market strengthens our capabilities and scale to assist clients with their most challenging issues.”

Leerink Swann Consulting assists clients with business strategy development, opportunity assessment, due diligence, R&D portfolio management, new business planning, new product planning and related issues. Its professionals have established several longstanding client relationships with large pharmaceutical firms, specialty pharmaceutical companies, biotech firms and medical and diagnostic device companies.

“Navigant has made a significant commitment to growing its life sciences practice,” said Doug Martin, Managing Director of Leerink Swann Consulting. “Joining Navigant Healthcare’s Life Sciences practice provides a valuable platform for our consultants and access to a broader array of expertise for our clients.”

No further details about the transaction were disclosed.

About Navigant Healthcare

Navigant Healthcare, a Navigant Consulting practice, works collaboratively across a spectrum of clients in the payer, provider and life sciences space. Our professionals consist of industry thought leaders, healthcare executives, clinicians, physicians and seasoned consultants who assist health systems, physician organizations, payers and life sciences companies in designing, developing and implementing integrated, technology-enabled solutions that create high-performing healthcare organizations. Navigant’s Life Sciences practice, a Navigant Healthcare subpractice, assists global life sciences companies in gaining competitive advantage by maximizing their business development, market access, strategic marketing, marketing research, brand management, and pricing and reimbursement initiatives. More information about Navigant Healthcare can be found at More information about Navigant’s Life Sciences expertise can be found at

About Navigant

Navigant (NYSE: NCI) is a specialized, global expert services firm dedicated to assisting clients in creating and protecting value in the face of critical business risks and opportunities. Through senior level engagement with clients, Navigant professionals combine technical expertise in Disputes and Investigations, Economics, Financial Advisory and Management Consulting, with business pragmatism in the highly regulated Construction, Energy, Financial Services and Healthcare industries to support clients in addressing their most critical business needs. More information about Navigant can be found at

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs